Victory Capital Management
NGNE icon

Victory Capital Management’s Neurogene NGNE Stock Holding History

Victory Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,094
Closed -$269K – 2798
2021
Q1 		$269K Sell
1,094
-38
-3% -$9.71K ﹤0.01% 2435
2020
Q4 		$319K Buy
1,132
+248
+28% +$60.6K ﹤0.01% 2264
2020
Q3 		$212K Buy
884
+250
+39% +$60.6K ﹤0.01% 2269
2020
Q2 		$211K Buy
+634
New +$165K ﹤0.01% 2286

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Victory Capital Management's NGNE Position: Q2 2021 in Review

Victory Capital Management sold out of Neurogene (NGNE) in Q2 2021, closing a stake of 1,094 shares — an estimated $269K sold.

Victory Capital Management first reported a position in NGNE in Q2 2020 and held it in 4 quarters. The position peaked at $319K in Q4 2020. 82 funds tracked by Wall St. Rank hold NGNE as of Q2 2021.

  • Victory Capital Management reported no remaining Neurogene position as of Q2 2021 after selling out during the quarter.
  • Victory Capital Management sold 1,094 Neurogene shares in Q2 2021, an estimated $269K.
  • Victory Capital Management first reported a position in Neurogene in Q2 2020 and held it in 4 quarters.
  • Victory Capital Management's Neurogene position peaked at $319K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q2 2021.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.